Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.894 |
High Similarity |
NPD2801 |
Approved |
0.8627 |
High Similarity |
NPD1934 |
Approved |
0.8609 |
High Similarity |
NPD1653 |
Approved |
0.8591 |
High Similarity |
NPD1511 |
Approved |
0.8581 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD3817 |
Phase 2 |
0.8477 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8452 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8395 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.838 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8267 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8221 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8165 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8138 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8098 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8095 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8069 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7917 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7908 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7875 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7847 |
Intermediate Similarity |
NPD3225 |
Approved |
0.784 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD37 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7733 |
Intermediate Similarity |
NPD1933 |
Approved |
0.773 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7669 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD2796 |
Approved |
0.764 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7639 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7613 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7564 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3267 |
Approved |
0.755 |
Intermediate Similarity |
NPD943 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD3749 |
Approved |
0.75 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1608 |
Approved |
0.745 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7448 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD3226 |
Approved |
0.74 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7394 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7391 |
Intermediate Similarity |
NPD920 |
Approved |
0.7389 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7357 |
Intermediate Similarity |
NPD228 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD411 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7294 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD17 |
Approved |
0.7255 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7192 |
Intermediate Similarity |
NPD9268 |
Approved |
0.719 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7176 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7134 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD3687 |
Approved |
0.703 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7014 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7012
|
Intermediate Similarity |
NPD6273 |
Approved |